Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
Attention Deficit Hyperactivity Disorder (ADHD) is common among adolescents seeking treatment
for marijuana dependence. The purpose of this study is to determine the use of atomoxetine in
treating adolescents who abuse marijuana and have ADHD. In addition, this study will assess
whether atomoxetine reduces ADHD symptoms as compared to a placebo. Finally, the study will
determine whether atomoxetine improves treatment retention and progress in adolescents with
ADHD and marijuana dependence.